U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Clarus IV-C, L.P. (0001700718)
State location: MA | State of Inc.: DE | Fiscal Year End: 1231
Business Address
101 MAIN STREET
SUITE 1210
CAMBRIDGE MA 02142
617-949-2200
Mailing Address
101 MAIN STREET
SUITE 1210
CAMBRIDGE MA 02142
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Talaris Therapeutics, Inc.
Current Name:Tourmaline Bio, Inc.
0001827506 2021-05-06 10 percent owner
Galera Therapeutics, Inc. 0001563577 2019-11-06 10 percent owner


Items 1 - 0

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016